Disulfican Limited (10823844) is a private limited with share capital incorporated on 16/06/2017 (8 years old) and registered in wolverhampton, WV95HD. The company operates under SIC code 72110 and is classified as Micro.
We are developing a groundbreaking new drug that’s going to revolutionize the treatment of aggressive cancers.starting from an original concept of re-purposing an established anti-alcoholism drug, we are presently taking our proprietary formulation of plga encapsulated disulfiram through pre-clinica...
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:31-03-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:04-02-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:04-10-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:04-10-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:20-06-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:28-03-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:13-12-2023
Change Person Director Company With Change Date
Category:Officers
Date:01-12-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:17-10-2023
Second Filing Of Director Appointment With Name
Category:Officers
Date:09-10-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:29-09-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:28-09-2023
Change Person Director Company With Change Date
Category:Officers
Date:27-09-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:03-08-2023
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:26-06-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:30-05-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:14-02-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:15-08-2022
Termination Director Company With Name Termination Date
Category:Officers
Date:15-08-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:08-08-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:16-06-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:24-02-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:26-07-2021
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:21-06-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:16-06-2020
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:09-01-2020
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:25-11-2019
Confirmation Statement With Updates
Category:Confirmation Statement
Date:18-06-2019
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:08-03-2019
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:27-11-2018
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:29-10-2018
Resolution
Category:Resolution
Date:21-08-2018
Appoint Person Director Company With Name Date
Category:Officers
Date:24-07-2018
Termination Director Company With Name Termination Date
Category:Officers
Date:24-07-2018
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:13-07-2018
Capital Allotment Shares
Category:Capital
Date:13-07-2018
Appoint Person Director Company With Name Date
Category:Officers
Date:13-07-2018
Appoint Person Director Company With Name Date
Category:Officers
Date:13-07-2018
Appoint Person Director Company With Name Date
Category:Officers
Date:13-07-2018
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:05-07-2018
Incorporation Company
Category:Incorporation
Date:16-06-2017
Innovate Grants
2
This company received a grant of £221068.0 for Translational Development Of A Novel Therapy For Malignant Mesothelioma. The project started on 01/07/2022 and ended on 30/06/2024.
This company received a grant of £147082.0 for Formulation And Testing Of Plga-Ds As An Anti-Cancer Therapy For Fda And Ema New Drug Application. The project started on 01/03/2018 and ended on 31/03/2020.
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating
Accounts
Typetotal exemption full
Due Date29/03/2026
Filing Date08/04/2025
Latest Accounts30/06/2024
Trading Addresses
Unit 8, Sidestrand, Pendeford Business Park, Wolverhampton, WV95HDRegistered
Science Centre, University Of Wolverhampton Scie, Wolverhampton, West Midlands, WV109RU
